Am J Transplant, Volume 22, Suppl 3 Archives - Page 33 of 190 - ATC Abstracts

2022 American Transplant Congress
HLA Alleles Add to Risk Stratification for CMV Infection in Renal Transplant Recipients
R. Patil¹, R. Prashar², M. Ramesh², A. Patel²
¹Wayne State University School of Medicine, Detroit, MI, ²Henry Ford Transplant Institute, Detroit, MI
*Purpose: Cytomegalovirus (CMV) is the most common viral infection that occurs after solid organ transplantation. The incidence of CMV infection or disease (I/d) varies based…
2022 American Transplant Congress
Discordant Histological Findings During Acute Rejection in a Combined Face and Hand Transplant Recipient
O. C. Onuh¹, J. Trilles¹, W. J. Rifkin¹, H. Brydges¹, B. F. Chaya¹, R. Rodriguez Colon¹, D. Boczar¹, D. J. Ceradini¹, E. D. Rodriguez¹, B. E. Gelb²
¹Hansjörg Wyss Department of Plastic Surgery, NYU Langone Health, New York, NY, ²Transplant Institute, NYU Langone Health, New York, NY
*Purpose: The purpose of this study is to evaluate histologic findings in a face and bilateral hand transplant recipient that was monitored with multi-site allograft…
2022 American Transplant Congress
Comparison of Vasodilators in Dual Vessel Normothermic Ex Vivo Liver Machine Perfusion of Rat Liver Grafts
J. M. Gassner, F. Strobl, J. Michelotto, K. Kristina, V. Muth, M. Zimmer, L. Gilles, S. Moosburner, J. Pratschke, I. Sauer, N. Raschzok
Department of Surgery, Experimental Surgery, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
*Purpose: Small animal models of normothermic ex vivo liver machine perfusion (NEVLP) comparable to clinically used protocols are vital to perform translational studies on organ…
2022 American Transplant Congress
Prognostic Factors for Mortality of COVID-19 Infection in Kidney Transplant Recipients in Thailand: A Nationwide Study
A. Banjongjit¹, N. Larpparisuth², K. Phonphok³, P. Homkrailas⁴, O. Traitanon⁵, P. Inkong⁶, S. Wongpraphairot⁷, A. Lumpaopong⁶, T. Supaporn⁶, C. Pongskul⁸
¹King Chulalongkorn Memorial Hospital, Bangkok, Thailand, ²Siriraj Hospital, Bangkok, Thailand, ³Rajavithi Hospital, Bangkok, Thailand, ⁴Bhumibol Adulyadej Hospital, Bangkok, Thailand, ⁵Thammasat Hospital, Pathum Thani, Thailand, ⁶Phramongkutklao Hospital, Bangkok, Thailand, ⁷Songklanagarind Hospital, Songkhla, Thailand, ⁸Khon Kaen University, Khon Kaen, Thailand
*Purpose: To investigate the mortality risk factors of COVID-19 infection among kidney transplant recipients (KTRs) in Thailand due to data scarcity in Asian populations.*Methods: We…
2022 American Transplant Congress
Older Living Donor Kidneys Are Associated with Worse Recipient and Graft Survival Compared to Younger Donors
A. P. Bregman¹, R. Spong¹, R. El-Rifai¹, K. Swanson¹, S. Jackson², S. Riad¹
¹Medicine, University of Minnesota, Minneapolis, MN, ²Analytics, Mhealth-Fairview, Minneapolis, MN
*Purpose: Older living donors (LDs) are accepted more frequently to expand the donor pool. We sought to evaluate recipient outcomes from older LDs >70y.*Methods: Utilizing…
2022 American Transplant Congress
The Role of Geography in Adult Heart Allocation Over the Last 5 Years
K. Bradbrook¹, R. Goff¹, R. Daly², S. Hall³
¹Research, United Network for Organ Sharing, Richmond, VA, ²Mayo Clinic, Rochester, MN, ³Baylor University Medical Center, Dallas, TX
*Purpose: In the last 5 years two policies have impacted the role of geography in adult heart allocation including the 2018 adult heart policy which…
2022 American Transplant Congress
SARS-CoV-2 Antibody Response by mRNA Vaccine Platform in Incrementally Immunosuppressed Patients
J. Mitchell¹, C. Connolly¹, T. Chiang¹, J. Alejo¹, W. Werbel¹, D. Segev¹, A. Massie²
¹Johns Hopkins University, Baltimore, MD, ²Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: This study compares SARS-CoV-2 antibody responses between the two-dose mRNA-1273 and BNT162b2 vaccine series across groups of incrementally immunosuppressed patients.*Methods: Semiquantitative testing for antibodies…
2022 American Transplant Congress
Ultra-Short Duration Prophylaxis for Hepatitis C Donor Positive to Recipient Negative Simultaneous Kidney/Pancreas Transplants
G. Gupta, I. Yakubu, A. Khan, R. Sterling
Virginia Commonwealth University, Richmond, VA
*Purpose: Recent trials have successfully utilized a strategy of hepatitis C virus (HCV) D+ [Donor nucleic acid test (NAT) positive]/R- (Recipient NAT negative) kidney and/or…
2022 American Transplant Congress
Outcomes of ABO-Incompatible Adult Living Donor Liver Transplantation for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria
B. Lee, J. Cho, H. Lee
Seoul National University Bundang Hospital, Seongnam-si, Korea, Republic of
*Purpose: Given the organ scarcity, ABO incompatible (ABOi) living donor liver transplantation (LDLT) emerged as a treatment option for hepatocellular carcinoma (HCC) and underlying liver…
2022 American Transplant Congress
Outcomes of Simultaneous Kidney Pancreas Transplantation in Patients with Type-1 and Type-2 Diabetes Mellitus
H. Shokouh-Amiri¹, M. S. Naseer², S. Badar¹, R. McMillan¹, D. Aultman¹, S. Tandukar¹, N. Singh¹, G. B. Zibari¹
¹John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA, ²Transplant, John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA
*Purpose: Advantages for type-2 diabetes mellitus (T2DM) patients receiving simultaneous kidney-pancreas transplantation (SKPT) as compared to kidney transplantation are shorter waiting times and availability of…